- €1.12bn
- €1.11bn
- €25.42m
Annual balance sheet for Medincell SA, fiscal year end - March 31st, EUR millions except per share, conversion factor applied.
C2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 50.6 | 27.2 | 6.47 | 19.5 | 71.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.61 | 5.71 | 12.3 | 6.71 | 7.77 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 56.3 | 34.1 | 19.6 | 27.3 | 80.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3.85 | 7.03 | 6.37 | 5.43 | 5.27 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 63.6 | 44.3 | 29.3 | 36.9 | 90.5 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 13.6 | 38.2 | 57 | 16.5 | 29.9 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 54.5 | 57.7 | 71.6 | 77.8 | 107 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 9.13 | -13.4 | -42.3 | -40.8 | -16.4 |
| Total Liabilities & Shareholders' Equity | 63.6 | 44.3 | 29.3 | 36.9 | 90.5 |
| Total Common Shares Outstanding |